D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Ionis Pharmaceuticals
IONS
$9.72B
| $45.2M | 0.06% |
557,191
+146,492
| +36% | +$11.9M |
|
|
SMAR
302
DELISTED
Smartsheet Inc.
SMAR
| $45.1M | 0.06% |
+1,106,288
| New | +$45.1M |
|
303
Omeros
OMER
$287M
| $44.9M | 0.06% |
2,585,438
+673,194
| +35% | +$11.7M |
|
|
DLPH
304
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
| $44.7M | 0.06% |
2,322,437
+743,192
| +47% | +$14.3M |
|
305
Pentair
PNR
$18.1B
| $44.6M | 0.06% |
1,001,483
+819,585
| +451% | +$36.5M |
|
306
InterDigital
IDCC
$7.74B
| $43.9M | 0.06% |
666,062
+147,832
| +29% | +$9.75M |
|
307
LKQ Corp
LKQ
$8.39B
| $43.9M | 0.06% |
1,547,897
-49,625
| -3% | -$1.41M |
|
308
Equity Lifestyle Properties
ELS
$11.9B
| $43.8M | 0.06% |
766,924
-240,160
| -24% | -$13.7M |
|
309
Ametek
AME
$43.6B
| $43.7M | 0.06% |
527,257
-35,833
| -6% | -$2.97M |
|
|
BERY
310
DELISTED
Berry Global Group, Inc.
BERY
| $43.2M | 0.06% |
872,970
+189,638
| +28% | +$9.38M |
|
311
Northrop Grumman
NOC
$83.3B
| $43.1M | 0.06% |
159,806
+133,891
| +517% | +$36.1M |
|
|
NBIS
312
Nebius Group N.V. Class A Ordinary Shares
NBIS
$15.3B
| $42.7M | 0.06% |
+1,243,235
| New | +$42.7M |
|
313
iShares Core S&P 500 ETF
IVV
$668B
| $42.7M | 0.06% |
150,000
| – | – |
|
314
Kellanova
K
$27.6B
| $42.5M | 0.06% |
789,371
+708,229
| +873% | +$38.2M |
|
|
MDRX
315
DELISTED
Veradigm Inc. Common Stock
MDRX
| $42.2M | 0.05% |
4,424,985
+1,035,753
| +31% | +$9.88M |
|
316
Voya Financial
VOYA
$7.3B
| $42.1M | 0.05% |
842,276
-189,545
| -18% | -$9.47M |
|
|
TVTY
317
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $42.1M | 0.05% |
2,396,146
+792,315
| +49% | +$13.9M |
|
318
JD.com
JD
$46.6B
| $42M | 0.05% |
1,394,478
-1,890,892
| -58% | -$57M |
|
319
Nasdaq
NDAQ
$54.5B
| $41.9M | 0.05% |
1,437,621
-1,939,887
| -57% | -$56.6M |
|
320
Toll Brothers
TOL
$14.3B
| $41.9M | 0.05% |
1,157,584
+349,831
| +43% | +$12.7M |
|
|
CTLT
321
DELISTED
CATALENT, INC.
CTLT
| $41.5M | 0.05% |
1,021,873
-1,347,357
| -57% | -$54.7M |
|
322
Nektar Therapeutics
NKTR
$843M
| $40.8M | 0.05% |
80,881
+28,239
| +54% | +$14.2M |
|
323
Stride
LRN
$7.17B
| $40.5M | 0.05% |
1,186,032
+120,611
| +11% | +$4.12M |
|
324
WESCO International
WCC
$10.6B
| $40.4M | 0.05% |
761,698
-12,921
| -2% | -$685K |
|
325
ASML
ASML
$313B
| $40.2M | 0.05% |
213,970
-478,862
| -69% | -$90M |
|